The Role of MRI in Assessing Residual Breast Cancer After Neoadjuvant Chemotherapy.
Emad Mofid Nassif RezkallahKamel MekhaeilSu Min Min TinRagai Sobhy HannaPublished in: The American surgeon (2023)
Magnetic resonance imaging is a good test to assess the residual tumor disease after NAC in breast cancer patients. However, cases of under- and overestimation are still seen, which require more caution when making a decision regarding the management of such cases.